Potassium-competitive acid blockers (P-CABs) reduce gastric acid secretion by inhibiting H+/K+ ATPase and have been proposed ...
With the U.S. FDA’s accelerated green light for its DNA therapy targeting recurrent respiratory papillomatosis (RRP), backers of Inovio Pharmaceuticals Inc. began mulling the confirmatory trial and ...
Heartflow Inc. reported data from the Navigate-PCI Registry which showed that the majority of physicians changed their treatment plan ahead of percutaneous coronary intervention (PCI) procedures after ...